Bio-Pharmaceutical Cell Disruption Systems

For biologic cell lysis (bacteria, yeast, algae and plants) cells can be efficiently disrupted with a pressure shock in order to collect the intracellular materials, drastically reducing the production time and costs.

Particle size reductions for the pharmaceutical industry can usually be accomplished at lower pressures than competing technology with appropriate selection of the most suitable homogenizing valve sizing, design and FDA grade wear resistant materials.

Unlike impinging flow type equipment, GEA Niro Soavi VHP Homogenizer can be easily scaled-up from the lab and pilot systems to industrial systems, consistently replicating the process results.

GEA Niro Soavi is the global technology and market leader for high pressure pumps and homogenizers for the food, pharmaceutical, chemical and biotechnology industries. It provides leading technology with the widest product range available, R&D facilities and first class after sales service to its business partners. GEA Niro Soavi maintains its leadership position through product innovation, reliability and an international sales and service network in order to be close to customers regardless and satisfy their expectations.